Skip to main content

Ikarian Capital, LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1778253 DALLAS, TX

Position in KPTI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,085,232
+$77,315 QoQ
Shares Held
733,435
+34.7% QoQ
Ownership
3.24%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Derivatives in KPTI

reported options exposure · as of Mar 31, 2026
CallValue
$5,124,400
CallShares
920,000
PutValue
$5,124,400
PutShares
920,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $653,059,812 across 106 Biotechnology names. KPTI ranks #44 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KPTI

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,124,400 920,000
2026-03-31 $5,124,400 920,000
2026-03-31 $0 0
2026-03-31 $4,085,232 733,435
2025-12-31 $4,007,917 544,554
2025-09-30 $178,260 27,257
2025-06-30 $117,477 27,257
2025-03-31 $101,941 27,257